
    
      Patients with MGC will be treated with TX or XELOX regimen. Before treatment, 14 days after
      treatment and after progression, the blood sample will be collected. Primary tumor blocks
      will also of collected. These samples will be used to detect predictive factors of the two
      types first line therapy.
    
  